Wellgistics Health Inc(WGRX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -41.45 | Insider Own | 59.94% | Shs Outstand | 2.4M | Perf Week | 20.14% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 1.1M | Perf Month | 3.83% |
| Enterprise Value | 0.04B | PEG | - | EPS next Q | - | Inst Own | 1.64% | Short Float | 10.02% | Perf Quarter | -46.67% |
| Income | -0.08B | P/S | 0.66 | EPS this Y | - | Inst Trans | -1.57% | Short Ratio | 0.19 | Perf Half Y | -82.65% |
| Sales | 0.01B | P/B | - | EPS next 5Y | - | ROA | -173.68% | Short Interest | 0.11M | Perf YTD | -82.38% |
| Book/sh | -6.31 | P/C | 184.96 | EPS past 3/5Y | -2054.2% - | ROE | -927.67% | 52W High | -96.39% ($97.50) | Perf Year | -94.03% |
| Cash/sh | 0.02 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 41.66% ($2.48) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -25.99% | Gross Margin | -69.22% | Volatility(W/M) | 8.33% 8.74% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 2.72 | Sales Y/Y TTM | -51.59% | Oper. Margin | -398.05% | ATR (14) | 0.42 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.03 | EPS Q/Q | 87.71% | Profit Margin | -545.72% | RSI (14) | 55.1 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.09 | Sales Q/Q | -85.64% | SMA20 | 19% ($2.96) | Beta | -1.46 | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | 2026/5/19 | SMA50 | -7.44% ($3.8) | Rel Volume | 0.96 | Prev Close | $2.71 |
| Employees | - | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | -76.66% ($15.08) | Avg Volume(3M) | 0.56M | Price | $3.52 |
| IPO | 2025/2/21 | Option/Short | No/Yes | Trades | 3356 | Volume | 536,627 | Change | 29.89% |
💊 A U.S. healthcare startup that bundles pharmaceutical wholesale, pharmacy, and prescription technology platforms under a single holding company structure. It's a micro-cap publicly traded company that supplies drugs to an independent pharmacy network through its wholesale business, operates regional specialty pharmacies, and is also developing a blockchain-based prescription tracking system called 'PharmacyChain.'
Over the past 1 year, on the lower side
96% below its 1-year high.
Traded about as much as usual. That is 96% of its average volume.
WGRX has weak earnings and a weak balance sheet
Losses exceed revenue. The business is barely earning yet.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $66. Peers typically go for $287.
Tap to view numbers
Holding long would have lost money
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 1.6%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
VTI Vanguard Morningstar Total Stock Market ETF <0.01% 
VXF Vanguard Extended Market Index ETF <0.01% It ranks #4 of 6 in the industry
Based on market cap of $9M.
POM#2 Pomdoctor Ltd $33M PER - 
PETS#3 Petmed Express Inc $26M PER - WGRX#4 Wellgistics Health Inc $9M PER - 
SCNX#4 Scienture Holdings Inc $5M PER - 
RDGT#5 Ridgetech Inc $3M PER - 
FAQ
What kind of company is WGRX?
WGRX belongs to the Healthcare sector and operates in the Pharmaceutical Retailers industry.
What is the market cap of WGRX?
The market cap of WGRX is approximately $9M, ranking 5,529 within its sector.
What is the 52-week high and low for WGRX?
WGRX has recorded a 52-week high of $97.50 and a low of $2.48.
